Insider Selling: David Eric Robinson Sells 4,000 Shares of athenahealth Stock (ATHN)
athenahealth (NASDAQ:ATHN) Director David Eric Robinson unloaded 4,000 shares of the stock in a transaction dated Thursday, October 3rd. The stock was sold at an average price of $111.01, for a total transaction of $444,040.00. Following the completion of the sale, the director now directly owns 2,058 shares of the company’s stock, valued at approximately $228,459. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link.
athenahealth (NASDAQ:ATHN) traded down 0.27% during mid-day trading on Friday, hitting $111.68. 208,109 shares of the company’s stock traded hands. athenahealth has a 52 week low of $56.33 and a 52 week high of $117.72. The stock’s 50-day moving average is $110.1 and its 200-day moving average is $98.96. The company has a market cap of $4.115 billion and a price-to-earnings ratio of 18663.33.
athenahealth (NASDAQ:ATHN) last announced its earnings results on Thursday, July 18th. The company reported ($0.08) earnings per share (EPS) for the quarter, missing the consensus estimate of $0.22 by $0.30. The company had revenue of $149.30 million for the quarter, compared to the consensus estimate of $148.24 million. During the same quarter in the previous year, the company posted $0.24 earnings per share. The company’s revenue for the quarter was up 44.3% on a year-over-year basis. On average, analysts predict that athenahealth will post $1.02 earnings per share for the current fiscal year.
A number of research firms have recently commented on ATHN. Analysts at Leerink Swann downgraded shares of athenahealth (NASDAQ:ATHN) from an “outperform” rating to a “market perform” rating in a research note to investors on Tuesday, September 24th. They now have a $120.00 price target on the stock. Separately, analysts at Zacks reiterated a “neutral” rating on shares of athenahealth (NASDAQ:ATHN) in a research note to investors on Tuesday, September 10th. They now have a $115.00 price target on the stock. Finally, analysts at Stephens initiated coverage on shares of athenahealth (NASDAQ:ATHN) in a research note to investors on Tuesday, September 10th. They set an “overweight” rating on the stock. Three research analysts have rated the stock with a sell rating, ten have assigned a hold rating and five have assigned a buy rating to the company. The company has a consensus rating of “Hold” and an average target price of $100.27.
athenahealth, Inc (NASDAQ:ATHN), is a business services company, which provides ongoing billing, clinical-related, and other related services to its customers.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.